ImmunityBio
IBRX
#3744
Rank
NZ$4.31 B
Marketcap
$5.06
Share price
-4.71%
Change (1 day)
-45.77%
Change (1 year)

ImmunityBio (IBRX) - Cash on Hand

Cash on Hand as of December 2024 : NZ$0.26 Billion

According to ImmunityBio's latest financial reports the company has NZ$0.26 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

ImmunityBio - Cash on Hand chart (from 2020 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31NZ$0.26 B-36.96%
2023-12-31NZ$0.42 B149.59%
2022-12-31NZ$0.16 B-63.64%
2021-12-31NZ$0.46 B248.73%
2020-12-31NZ$0.13 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.45 B 70.86%๐Ÿ‡บ๐Ÿ‡ธ USA